ONCOLYTICS BIOTECH
Live / Registered — Registered and renewed (as of 19 Apr 2018)
What this means for you
Registered since 30 Dec 2008. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 30 Dec 2018).
Record
- Serial number
- 77240455
- Registration number
- 3555516
- Mark type
- Stylized text
- Filed
- 27 Jul 2007
- Registered
- 30 Dec 2008
- Next maintenance due
- 30 Dec 2018
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 005 — Pharmaceuticals: HOUSEMARK FOR PHARMACEUTICAL PRODUCTS; PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF CANCER
- Class 042 — Scientific and technological services: MEDICAL AND SCIENTIFIC RESEARCH, NAMELY, CONDUCTING CLINICAL TRIALS; MEDICAL AND SCIENTIFIC RESEARCH SERVICES IN THE FIELD OF CANCER TREATMENT
Owner
- Oncolytics Biotech Inc., Calgary, Alberta, CA
- Oncolytics Biotech Inc., Calgary, CA
Prosecution history
- 30 Dec 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Dec 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Dec 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Dec 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Dec 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 19 Apr 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 19 Apr 2018 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 19 Apr 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 19 Apr 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Apr 2018 — TEAS SECTION 8 & 9 RECEIVED
- 30 Dec 2017 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 31 Dec 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 31 Dec 2014 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 27 Dec 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Dec 2014 — TEAS SECTION 8 RECEIVED